Is Apple the Teflon Tech Stock? And the Latest Moves in the Weight Loss Drug Space 6/26/23
CNBC's "Fast Money"
00:00
The Size of the Weight Loss Market
The orals I think will be definitely viewed as a drug for the masses so to speak. There are other drugs out there that could be used in higher BMI patients. Monjaro itself could be close to $100 billion of an opportunity, not just talking about diabetes and obesity but including all the studies that Lilly is working on.
Play episode from 30:26
Transcript
